Ignite Creation Date:
2024-10-26 @ 3:39 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06576518
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-08-23
Brief Title:
Exercise Intervention in Patients With Metabolic Syndrome and Renal Disease a Prospective Study
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Exercise Intervention in Patients With Metabolic Syndrome and Renal Disease a Prospective Study EXRED
Status:
COMPLETED
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
EXRED
Brief Summary:
INTRODUCTION Obesity OB and metabolic syndrome MetS are risk and progression factors for chronic kidney disease CKD However the effect of OBMetS intervention with exercise on renal function progression and proteinuria is unknown
OBJECTIVE To analyse the effect of therapeutic exercise on MetS and main renal outcomes in patients with CKD
METHODOLOGY This is a 6-month prospective exploratory study Patients with stablished CKD 1-4 and MetS were treated with individualised incremental exercise aerobic and resistance Simultaneously a plan of adherence was set up to promote compliance Renal and metabolic outcomes were collected The main renal parameters were proteinuria in isolated urine samples and glomerular filtration rate GFR measured by iohexol DBS at 0 3 and 6 months At the same time points metabolic outcomes were measured weight dyslipidemia insulin resistance and hypertension
OBJECTIVE To analyse the effect of therapeutic exercise on MetS and main renal outcomes in patients with CKD
METHODOLOGY This is a 6-month prospective exploratory study Patients with stablished CKD 1-4 and MetS were treated with individualised incremental exercise aerobic and resistance Simultaneously a plan of adherence was set up to promote compliance Renal and metabolic outcomes were collected The main renal parameters were proteinuria in isolated urine samples and glomerular filtration rate GFR measured by iohexol DBS at 0 3 and 6 months At the same time points metabolic outcomes were measured weight dyslipidemia insulin resistance and hypertension
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None